LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | SB590885 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 4026 | 3769 | 1.0681 | 1.0961 |
BT-20 | PIK-93 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3007 | 3769 | 0.7977 | 0.7147 |
BT-20 | KIN001-043 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3298 | 3769 | 0.8751 | 0.8238 |
BT-20 | Alpelisib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1241 | 3769 | 0.3292 | 0.0538 |
BT-20 | Luminespib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1139 | 3769 | 0.3023 | 0.0159 |
BT-20 | A443654 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 469 | 3769 | 0.1246 | -0.2349 |
BT-20 | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1671 | 3769 | 0.4433 | 0.2147 |
BT-20 | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 1097 | 2962 | 3769 | 0.7859 | 0.6979 |
BT-20 | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1560 | 3769 | 0.4140 | 0.1734 |
BT-20 | WH-4-025 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1688 | 3769 | 0.4480 | 0.2213 |
BT-20 | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 2046 | 3769 | 0.5428 | 0.3550 |
BT-20 | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1312 | 3769 | 0.3481 | 0.0804 |
BT-20 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3666 | 3769 | 0.9725 | 0.9613 |
BT-20 | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 732 | 3769 | 0.1942 | -0.1367 |
BT-20 | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3683 | 3769 | 0.9772 | 0.9679 |
BT-20 | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 2671 | 3769 | 0.7088 | 0.5892 |
BT-20 | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 1097 | 477 | 3769 | 0.1266 | -0.2320 |
BT-20 | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 593 | 3769 | 0.1574 | -0.1886 |
BT-20 | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 516 | 3769 | 0.1371 | -0.2173 |
BT-20 | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3450 | 3769 | 0.9153 | 0.8806 |
BT-20 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2909 | 3769 | 0.7717 | 0.6780 |
BT-20 | CP466722 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3520 | 3769 | 0.9338 | 0.9066 |
BT-20 | Crizotinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1566 | 3769 | 0.4156 | 0.1757 |
BT-20 | Momelotinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2330 | 3769 | 0.6182 | 0.4614 |
BT-20 | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1197 | 3769 | 0.3176 | 0.0375 |